Dinney CPN - Search Results

1

Long-Term Oncological Outcomes in Patients Diagnosed With Nonmetastatic Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson Cancer Center Experience.

Sood A, Rudzinski JK, Labbate CV, Hensley PJ, Bree KK, Guo CC, Alhalabi O, Campbell MT, Siefker-Radtke AO, Navai N, Dinney CPN, Gao J, Kamat AM. Sood A, et al. Among authors: dinney cpn. J Urol. 2024 Feb;211(2):241-255. doi: 10.1097/JU.0000000000003778. Epub 2023 Nov 3. J Urol. 2024. PMID: 37922370

2

Sentinel lymph node dissection for penile carcinoma: the M. D. Anderson Cancer Center experience.

Pettaway CA, Pisters LL, Dinney CP, Jularbal F, Swanson DA, von Eschenbach AC, Ayala A. Pettaway CA, et al. J Urol. 1995 Dec;154(6):1999-2003. J Urol. 1995. PMID: 7500444

3

Lymphoepithelioma of the bladder: a clinicopathological study of 3 cases.

Dinney CP, Ro JY, Babaian RJ, Johnson DE. Dinney CP, et al. J Urol. 1993 Apr;149(4):840-1. doi: 10.1016/s0022-5347(17)36228-6. J Urol. 1993. PMID: 8455255

4

Risk of urethral, vaginal and cervical involvement in patients undergoing radical cystectomy for bladder cancer: results of a contemporary cystectomy series from M. D. Anderson Cancer Center.

Chen ME, Pisters LL, Malpica A, Pettaway CA, Dinney CP. Chen ME, et al. J Urol. 1997 Jun;157(6):2120-3. J Urol. 1997. PMID: 9146596 Review.

5

Nephrectomy and vena caval thrombectomy in patients with metastatic renal cell carcinoma.

Slaton JW, Balbay MD, Levy DA, Pisters LL, Nesbitt JC, Swanson DA, Dinney CP. Slaton JW, et al. Urology. 1997 Nov;50(5):673-7. doi: 10.1016/s0090-4295(97)00329-4. Urology. 1997. PMID: 9372873 Review.

6

Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?

Sweeney P, Millikan R, Donat M, Wood CG, Radtke AS, Pettaway CA, Grossman HB, Dinney CP, Swanson DA, Pisters LL. Sweeney P, et al. J Urol. 2003 Jun;169(6):2113-7. doi: 10.1097/01.ju.0000067601.29966.4a. J Urol. 2003. PMID: 12771730 Clinical Trial.

7

Clinical presentation and outcome of high-grade urinary bladder leiomyosarcoma in adults.

Rosser CJ, Slaton JW, Izawa JI, Levy LB, Dinney CP. Rosser CJ, et al. Urology. 2003 Jun;61(6):1151-5. doi: 10.1016/s0090-4295(03)00021-9. Urology. 2003. PMID: 12809885

8

Nuclear factor-kappaB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8.

Karashima T, Sweeney P, Kamat A, Huang S, Kim SJ, Bar-Eli M, McConkey DJ, Dinney CP. Karashima T, et al. Clin Cancer Res. 2003 Jul;9(7):2786-97. Clin Cancer Res. 2003. PMID: 12855659

9

Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy.

Slaton JW, Millikan R, Inoue K, Karashima T, Czerniak B, Shen Y, Yang Y, Benedict WF, Dinney CP. Slaton JW, et al. J Urol. 2004 Feb;171(2 Pt 1):570-4. doi: 10.1097/01.ju.0000108845.91485.20. J Urol. 2004. PMID: 14713761

10

The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors in vivo.

Kamat AM, Karashima T, Davis DW, Lashinger L, Bar-Eli M, Millikan R, Shen Y, Dinney CP, McConkey DJ. Kamat AM, et al. Mol Cancer Ther. 2004 Mar;3(3):279-90. Mol Cancer Ther. 2004. PMID: 15026548

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

433 results

Search Page